Beyond cardiovascular implications, ATP1A3 mutations have been implicated in neurological disorders such as Alternating Hemiplegia of Childhood (AHC) and rapid onset dystonia-parkinsonism (RDP), conditions characterized by dysfunctional neuronal excitability[19]. Here, ATP1A3 is linked to alternating hemiplegia of childhood.